v3.26.1
Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid- In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   12,823,665    
Beginning balance at Dec. 31, 2023 $ 186,024 $ 0 $ 373,178 $ (187,154)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 8,320   8,320  
Common stock issued upon exercise of stock options (in shares)   92,653    
Common stock issued upon exercise of stock options 1,676   1,676  
Shares issued upon the exercise of pre-funded warrants (in shares)   103,407    
Issuance of common shares and pre-funded warrants in a private financing, net of $10,501 offering costs (in shares)   1,835,000    
Issuance of common shares and pre-funded warrants in a private financing, net of $10,501 offering costs 189,499   189,499  
Net loss $ (75,144)     (75,144)
Ending balance (in shares) at Dec. 31, 2024 14,854,725 14,854,725    
Ending balance at Dec. 31, 2024 $ 310,375 $ 0 572,673 (262,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 14,183   14,183  
Common stock issued upon exercise of stock options (in shares) 20,735 20,735    
Common stock issued upon exercise of stock options $ 266   266  
Issuance of common stock in at-the-market offering, net of offering costs (in shares)   1,200,000    
Issuance of common stock in at-the-market offering, net of offering costs 30,330   30,330  
Exchange of common stock for pre-funded warrants (in shares)   (667,500)    
Common stock issued upon vesting of restricted stock units (in shares)   73,158    
Common stock issued under Employee Stock Purchase Plan (in shares)   8,682    
Common stock issued under Employee Stock Purchase Plan 84   84  
Net loss $ (90,351)     (90,351)
Ending balance (in shares) at Dec. 31, 2025 15,489,800 15,489,800    
Ending balance at Dec. 31, 2025 $ 264,887 $ 0 $ 617,536 $ (352,649)